A MULTICENTER, RANDOMIZED, INVESTIGATOR-AND SUBJECT-BLIND, PLACEBO-CONTROLLED, TREATMENT SEQUENCE STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF UCB7665 IN SUBJECTS WITH MODERATE TO SEVERE MYASTHENIA GRAVIS
Principal Investigator(s)
Bhavaraju-Sanka, Ratna K.
Funded by
UCB BIOSCIENCES INC
Research Start Date
Status
Active